Who
Rita J. Balice-Gordon
Director
Company insider
Files Form 4 as: Director, Collegium Pharmaceutical.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $172K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 24 Sep 2020
- Last trade
- 14 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —8,741 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —8,741 at $0.00 | filing |
| 5 Dec 2025filed 9 Dec 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $172K3,650 at $47.03 | filing |
| 15 May 2025filed 19 May 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —9,791 at $0.00 | filing |
| 16 May 2024filed 16 May 2024 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —7,693 at $0.00 | filing |
| 18 May 2023filed 19 May 2023 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —9,792 at $0.00 | filing |
| 19 May 2022filed 23 May 2022 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —14,035 at $0.00 | filing |
| 20 May 2021filed 24 May 2021 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —9,941 at $0.00 | filing |
| 24 Sep 2020filed 28 Sep 2020 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,055 at $0.00 | filing |
| 24 Sep 2020filed 28 Sep 2020 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —5,027 at $0.00 | filing |
News
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Has Consensus Price Target of $48.71COLL · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Rita J. Balice-Gordon; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.